DigiCon

Prevalence of CKD in your practice? *

< 20%

31-40%

20-30%

> 40%

How does incidence of CKD vary as per gender? *

More commonly seen in males

More commonly seen in females

How does the incidence of CKD vary as per age group? *

<30 years

30-50 years

51-75 years

>75 years

Common causes of CKD that you normally observe in your practice? (Tick all that apply)*

Type 1 and 2 diabetes

Pyelonephritis

Hypertension

AKI

Any other

Percentage of CKD patients in your practice who have hyperuricemia? *

<30%

31-50%

51-75%

>75%

Other common comorbidities observed in your CKD patients with hyperuricemia? (Tick all that apply)*

Hypertension

Diabetes

Dyslipidemia

Any other

At what uric acid levels, do you treat your CKD patients for hyperuricemia? *

> 6 mg / dL

> 7 mg / dL

> 8 mg/ dL

> 9 mg/ dL

Any other concomitant test you conduct in addition to uric acid levels? (Tick all that apply)*

Serum Creatinine

BUN

Microalbuminuria

Any other

Management regimen for hyperuricemia in CKD patients? *

Uricostatics

Uricosurics

Phosphate Binders

Any other

Common Lifestyle modifications suggested by you to patients suffering from hyperuricemia associated with CKD? *

Rank the drugs used to control hyperuricemia in CKD patients.? *
(1 – Excellent, 2 – Very Good, 3 – Good, 4 – Average)

Febuxostat
Allopurinol
Probenecid
Colchicine

What percentage of your CKD patients currently undergoing hyperuricemia treatment are on ? *

Febuxostat	Allopurinol	Probenecid	Colchicine
< 40%	< 40%	< 40%	< 40%
40-60%	40-60%	40-60%	40-60%
60-80%	60-80%	60-80%	60-80%
>90%	>90%	>90%	>90%

Dosage and Duration for hyperuricemia treatment in CKD patients.? *

Molecule	Dose (in mg)	Duration (in weeks)
Febuxostat
Allopurinol
Probenecid
Colchicine

Rank the safety profile for below mentioned ULTs as per your current observation? *
(1 – Excellent, 2 – Very Good, 3 – Good, 4 – Poor)

Febuxostat
Allopurinol
Probenecid
Colchicine

In CKD patients with controlled uric acid levels, do you continue treatment? *

Yes

No

If Yes, what will be the treatment regimen and for what duration? *

Patient’s adherence to your treatment regimen for Hyperuricemia would be ? *

<50%

50-70%

71-90%

>90%

In case of non-compliance, what are the key factors? *

Cost of therapy

Availability of drugs

Dosage

Safety

Any other

Which other regimen do you prescribe in patient with CKD ? *

Probiotic

Calcium binders

Phosphate binders

Protein supplements

Any other

At what stage of CKD do you refer patients to nephrologist ? *

CKD 3a

CKD 3b

CKD 4

CKD 5

{{ $ActivityTypeName }}

Survey Name: cHeCKD from clinician perspective (correlation between hyperuricemia and CKD)